Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a73cee5001ad08339ae751c10d9abf71 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-438 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4468 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-501 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397 |
filingDate |
2017-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ddcf480314c3f0950f7687d8d2bb248 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4cca54cb92caeb82f271a3035129e9a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d7b41c1c8a309e39d138b9ca86ca757 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5767af322ba5391c7f7c24203a5167a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5aa9adb79b91cc60a0082ed1f17b426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fae0860d5ee0ce6585886f9bd1fb7cd7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b132d36eb2519e6fc743d9f1059fbae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9c4f2c5129515a72d935373151fd98c |
publicationDate |
2018-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CL-2017003040-A1 |
titleOfInvention |
Cyclopropylamine as an inhibitor of lsd1 (divisional of application 2027-2016). |
abstract |
<p> THIS INVENTION IS DIRECTED TO CICLOPROPILAMINE DERIVATIVES THAT ARE INHIBITORS OF THE EFFECTIVE LSD1 FOR THE TREATMENT OF DISEASES LIKE CANCER. </p> |
priorityDate |
2014-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |